MYC and Miyoshi myopathy: The decrease in cell viability (Fig. 3a) and MYC protein levels (Fig. 3b, c) in L363 multiple myeloma (MM) cells and other MM cells (Supplementary Table 3) was sustained over the entirety of the 72-h time course.